Login / Signup

Adjuvant system AS01: from mode of action to effective vaccines.

François RomanWivine BurnyMaria Angeles CeregidoBéatrice LaupèzeStéphane T TemmermanLucile WarterMargherita Coccia
Published in: Expert review of vaccines (2024)
Initial expectations that adjuvantation with AS01 could support effective vaccine responses and contribute to disease control have been realized. Investigation of the utility of AS01 in vaccines to prevent other challenging diseases, such as tuberculosis, is ongoing, together with efforts to fully define its mechanisms of action in different vaccine settings.
Keyphrases
  • mycobacterium tuberculosis
  • early stage
  • pulmonary tuberculosis
  • emergency department
  • hiv aids
  • hepatitis c virus
  • hiv infected
  • human immunodeficiency virus
  • antiretroviral therapy